Related Experiment Video

Updated: May 19, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Myotonic dystrophy: is a narrow focus obscuring the rest of the field?

Mani S Mahadevan1

  • 1Department of Pathology, University of Virginia, Charlottesville, Virginia, USA. mahadevan@virginia.edu

Current Opinion in Neurology
|August 16, 2012
PubMed
Abstract

Insights

Myotonic dystrophy (DM1) pathogenesis involves RNA toxicity, including microRNA dysregulation and novel protein interactions. Therapeutic strategies are advancing rapidly, focusing on antisense and small molecule treatments.

Area of Science:

  • Molecular Biology
  • Genetics
  • RNA Biology

Background:

  • Myotonic dystrophies (DM1 and DM2) exemplify RNA toxicity in disease.
  • Understanding DM1 pathogenesis is crucial for therapeutic advancements.

Purpose of the Study:

  • Review recent developments in DM1 pathogenesis.
  • Highlight progress in translational and therapeutic strategies for DM1.

Main Methods:

  • Review of current literature on DM1 pathogenesis.
  • Analysis of emerging RNA toxicity mechanisms.
  • Assessment of therapeutic development strategies.

Main Results:

  • RNA toxicity in DM1 involves antisense transcription, microRNA dysregulation, and non-ATG translation.
  • New RNA-binding proteins (Staufen 1, DDX5) and MBNL1 functions are identified.
  • Small molecules targeting CUG-MBNL1 interactions are under development.

Conclusions:

  • DM1 pathogenesis is more complex than simple spliceopathy.
  • Antisense and small molecule therapies are progressing rapidly.
  • Biomarker discovery and outcome measures are key for clinical trials.

More Related Videos

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies14:10

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies

Published on: January 31, 2013

Tissue Triage and Freezing for Models of Skeletal Muscle Disease05:58

Tissue Triage and Freezing for Models of Skeletal Muscle Disease

Published on: July 15, 2014

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
The Sarcomere01:08

The Sarcomere

A sarcomere is a microscopic segment repeating in a myofibril. The sarcomere fundamentally consists of two main myofilaments: thick filaments called myosin and thin filaments called actin. These filaments interact by sliding past each other in response to stimulus. In addition to myosin and actin, several other proteins, such as tropomyosin, troponin, titin, nebulin, myomesin, α-actinin, and dystrophin, play crucial roles in regulating, structuring, and functioning of the sarcomere.
Each myosin...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...